awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38764214-2F218C67-6C4C-49A0-A8AE-6E2DC6750480
Q38764214-2F218C67-6C4C-49A0-A8AE-6E2DC6750480
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38764214-2F218C67-6C4C-49A0-A8AE-6E2DC6750480
Predicting dose sparing benefit and bleeding risk of pharmacokinetic-based personalized prophylactic dosing of factor VIII products.
P2860
Q38764214-2F218C67-6C4C-49A0-A8AE-6E2DC6750480
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38764214-2F218C67-6C4C-49A0-A8AE-6E2DC6750480
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
80b7c721ee335732d1a76dfeb3cf3ff26b104dd9
P2860
Treatment trends for haemophilia A and haemophilia B in the United States: results from the 2010 practice patterns survey.